ATRC-101,Pembrolizumab
Atreca,merck
['arto']
the atreca team is headed to #asco23 this weekend! dr. bartosz chmielowski will be presenting an interim update from our phase 1b study of atrc-101. if you re at asco this year, check out the presentation: #oncology #immunotherapy 
Biotech company developing novel cancer therapeutics based on a deep understanding of the human immune response